Page 7,065«..1020..7,0647,0657,0667,067..7,0707,080..»

QF honours stem cell researchers

Posted: Published on March 1st, 2012

Research on preventing breast cancer recurrence, using organ regeneration to combat obesity-related diseases, and enabling vascular repair for patients suffering from cardiovascular disease has received awards at the ongoing Qatar International Conference on Stem Cell Science and Policy 2012. The award ceremony hosted by Qatar Foundation for Education, Science and Community Development at Qatar National Convention Centre recognised two professional researchers and one student researcher for excellence in stem cell research, with the research exhibited through poster presentations during the conference. Leaders from QF and top figures in the stem cell science and ethics field congratulated the award recipients. Dr Abdelali Haoudi, vice president for research at QF, said: We are truly impressed with the research presented this year in poster presentations, as well as in the oral presentations and panel discussions taking place throughout the conference. He added: Through this conference, we hope to drive further exploration in this field that will lead to even greater progress in applying stem cell science to prevent and treat diseases afflicting communities both in Qatar and around the world. The three posters were selected for recognition by a review committee, comprised of academics, researchers and scientists, including Nobel Laureates and international experts. … Continue reading

Comments Off on QF honours stem cell researchers

Bioheart Issues Shareholder Letter Announcing Progress

Posted: Published on March 1st, 2012

More Topics: Choose a Sector Accounting Firms Advertising/Media/Communications Capital CEO/Board General Business Health/Biotech Internet/Technology Investment Firms Law Firms Mergers & Acquisitions Money Managers People Private Companies Public Companies Venture Capital Posted March 1, 2012 SUNRISE, Fla., -- Dear Shareholders, It is with great enthusiasm that I am pleased to inform you about Bioheart's progress during 2011 and announce several new initiatives for 2012. We have boosted our senior management team, entered into several valuable partnerships and agreements, identified new markets and alternative sources of revenue and seen tangible results regarding continued clinical trials. 2011 was a year of steady, continuous movement for the company. We completed an Investigational New Drug (IND) application to the FDA for the ANGEL trial. The clinical protocol is designed to assess the safety and cardiovascular effects of intramyocardialimplantation of autologous adipose derived stem cells (LipiCellTM) in patients with chronic ischemic cardiomyopathy. LipiCellTM is currently being evaluated in the Phase I/II trial in Mexico in which 15 patients have been treated. These patients are demonstrating improvements in ejection fraction and exercise capacity. We generated over $1.4 million from investments and revenues this past year. Overall debt was reduced by almost $400,000 and our monthly burn rate … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on Bioheart Issues Shareholder Letter Announcing Progress

Bioheart Issues Shareholder Letter Announcing Progress and New Initiatives

Posted: Published on March 1st, 2012

SUNRISE, Fla., March 1, 2012 (GLOBE NEWSWIRE) -- Dear Shareholders, It is with great enthusiasm that I am pleased to inform you about Bioheart's progress during 2011 and announce several new initiatives for 2012. We have boosted our senior management team, entered into several valuable partnerships and agreements, identified new markets and alternative sources of revenue and seen tangible results regarding continued clinical trials. 2011 was a year of steady, continuous movement for the company. We completed an Investigational New Drug (IND) application to the FDA for the ANGEL trial. The clinical protocol is designed to assess the safety and cardiovascular effects of intramyocardialimplantation of autologous adipose derived stem cells (LipiCell(TM)) in patients with chronic ischemic cardiomyopathy. LipiCell(TM) is currently being evaluated in the Phase I/II trial in Mexico in which 15 patients have been treated. These patients are demonstrating improvements in ejection fraction and exercise capacity. We generated over $1.4 million from investments and revenues this past year. Overall debt was reduced by almost $400,000 and our monthly burn rate was reduced by 20%. We renewed our $980,000 loan from Seaside National Bank and Trust with the continued support of long time shareholders, Dan Marino and Jason Taylor, who … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on Bioheart Issues Shareholder Letter Announcing Progress and New Initiatives

Factbox – Neurotechnologies in spotlight of UK ethics review

Posted: Published on March 1st, 2012

LONDON (Reuters) - Britain's Nuffield Council on Bioethics, which examines ethical issues raised by new developments in biology and medicine, launched a consultation on Thursday on the ethics of new technologies and devices that intervene in the human brain. The three main areas of the group's focus are brain-computer interfaces, neurostimulation and neural stem cell therapy. Here are some details about each area of research and how it is being explored. * Brain computer interfaces (BCIs) BCIs measure and analyse a person's brain signals and convert them into an output such as movement. A paralysed person, for example, could use a BCI to operate a wheelchair, or someone who has extreme difficulty speaking could use a BCI to communicate via a computer voice. These sorts of applications have been shown to be successful in a few reported cases, but the technology has not yet been developed for regular clinical use and there are questions over whether these technologies are reliable enough for use in everyday life. Military applications, such as remote control of vehicles and machinery are not yet in wide use but are being researched and tested, mainly in the United States. Some commercial BCI developments are already on … Continue reading

Posted in Stem Cell Human Trials | Comments Off on Factbox – Neurotechnologies in spotlight of UK ethics review

Meet Cord Blood Registry’s Leader of Laboratory Operations – Video

Posted: Published on March 1st, 2012

28-02-2012 16:31 Learn more about cord blood stem cells here http://www.cordblood.com Cord Blood Registry takes pride in leading the cord blood banking industry with its state-of-the-art lab. Meet Kristen, who leads the effort to make sure we're providing our clients with the best once their babies' stem cells arrive in Tucson. Kristen is one of the many people who make sure that, from that first phone call to the day your baby's stem cells are collected and stored, you receive the industry's best service and support. For more information on CBR's processes, visit: http://www.cordblood.com Read the rest here: Meet Cord Blood Registry's Leader of Laboratory Operations - Video … Continue reading

Posted in Cell Medicine | Comments Off on Meet Cord Blood Registry’s Leader of Laboratory Operations – Video

Meet Cord Blood Registry's Leader of Laboratory Operations – Video

Posted: Published on March 1st, 2012

28-02-2012 16:31 Learn more about cord blood stem cells here http://www.cordblood.com Cord Blood Registry takes pride in leading the cord blood banking industry with its state-of-the-art lab. Meet Kristen, who leads the effort to make sure we're providing our clients with the best once their babies' stem cells arrive in Tucson. Kristen is one of the many people who make sure that, from that first phone call to the day your baby's stem cells are collected and stored, you receive the industry's best service and support. For more information on CBR's processes, visit: http://www.cordblood.com Read the rest here: Meet Cord Blood Registry's Leader of Laboratory Operations - Video … Continue reading

Posted in Cell Medicine | Comments Off on Meet Cord Blood Registry's Leader of Laboratory Operations – Video

How Organic Medical Clinic’s Laser Can Help You – Video

Posted: Published on March 1st, 2012

29-02-2012 12:13 Low-Level Laser Therapy is a completely safe, noninvasive, nonthermal therapy in which a special type of light penetrates the surface of the skin and underlying tissues to stimulate natural healing in the body. The body's cells are exposed to photon energy, which in turn: Reduces pain Reduces inflammation Increases circulation Increases cellular ATP production Releases tight muscles (both smooth and striated) Speeds bone repair FDA Approves Low-Level Laser for Osteoarthritis Billions of dollars equal a staggering loss in the United States economy due to medical costs and decrease in productivity. The culprit, osteoarthritis. However, the United States Food and Drug Administration (FDA) cleared a new therapy that alleviates pain and inflammation with no side effects. This marks the first low-level laser to be cleared by the FDA for treating osteoarthritis of the hand. This therapy is the Q-Laser System, a low-level laser, now available in our clinics in San Diego and Oceanside. Osteoarthritis cannot currently be cured, but effective treatments can improve the quality of life of millions of people. To many people, it comes as exciting news that the FDA has recently approved a low-level laser treatment, the Q-1000 Laser, for treating osteoarthritis in the hands. The … Continue reading

Posted in Cell Medicine | Comments Off on How Organic Medical Clinic’s Laser Can Help You – Video

How Organic Medical Clinic's Laser Can Help You – Video

Posted: Published on March 1st, 2012

29-02-2012 12:13 Low-Level Laser Therapy is a completely safe, noninvasive, nonthermal therapy in which a special type of light penetrates the surface of the skin and underlying tissues to stimulate natural healing in the body. The body's cells are exposed to photon energy, which in turn: Reduces pain Reduces inflammation Increases circulation Increases cellular ATP production Releases tight muscles (both smooth and striated) Speeds bone repair FDA Approves Low-Level Laser for Osteoarthritis Billions of dollars equal a staggering loss in the United States economy due to medical costs and decrease in productivity. The culprit, osteoarthritis. However, the United States Food and Drug Administration (FDA) cleared a new therapy that alleviates pain and inflammation with no side effects. This marks the first low-level laser to be cleared by the FDA for treating osteoarthritis of the hand. This therapy is the Q-Laser System, a low-level laser, now available in our clinics in San Diego and Oceanside. Osteoarthritis cannot currently be cured, but effective treatments can improve the quality of life of millions of people. To many people, it comes as exciting news that the FDA has recently approved a low-level laser treatment, the Q-1000 Laser, for treating osteoarthritis in the hands. The … Continue reading

Posted in Cell Medicine | Comments Off on How Organic Medical Clinic's Laser Can Help You – Video

Factbox: Neurotechnologies in spotlight of UK ethics review

Posted: Published on March 1st, 2012

LONDON (Reuters) - Britain's Nuffield Council on Bioethics, which examines ethical issues raised by new developments in biology and medicine, launched a consultation on Thursday on the ethics of new technologies and devices that intervene in the human brain. The three main areas of the group's focus are brain-computer interfaces, neurostimulation and neural stem cell therapy. Here are some details about each area of research and how it is being explored. * Brain computer interfaces (BCIs) BCIs measure and analyze a person's brain signals and convert them into an output such as movement. A paralyzed person, for example, could use a BCI to operate a wheelchair, or someone who has extreme difficulty speaking could use a BCI to communicate via a computer voice. These sorts of applications have been shown to be successful in a few reported cases, but the technology has not yet been developed for regular clinical use and there are questions over whether these technologies are reliable enough for use in everyday life. Military applications, such as remote control of vehicles and machinery are not yet in wide use but are being researched and tested, mainly in the United States. Some commercial BCI developments are already on … Continue reading

Posted in Cell Medicine | Comments Off on Factbox: Neurotechnologies in spotlight of UK ethics review

New Jersey bans synthetic marijuana

Posted: Published on March 1st, 2012

New Jersey Attorney General Jeffrey S. Chiesa on Wednesday announced a statewide ban on all forms of synthetic marijuana, the so-called designer drug that mimics the effects of marijuana. The concoction, also known as K2 and Spice, is the third most commonly abused drug by high school seniors, behind marijuana and prescription drugs, according to a 2011 study funded by the National Institute on Drug Abuse. Side effects include violent seizures, dangerously elevated heart rates, and hallucinations, according to the institute and the U.S. Drug Enforcement Administration. New Jersey's ban - in an emergency order pending legislative action - prohibits the manufacture, distribution, and sale of any of the hundreds of chemical combinations that mirror marijuana's effect, and is more sweeping than previous efforts. The drug will now be considered a controlled dangerous substance, like cocaine and heroin. Violators could face three to five years in prison and a fine of up to $25,000, officials said. Under state law, officials can reclassify and restrict the availability of chemicals that have a high potential for abuse and no accepted medical use. Chiesa said authorities wanted to ban all possible variants of the drug to prevent manufacturers and dealers from sidestepping the … Continue reading

Posted in Drug Side Effects | Comments Off on New Jersey bans synthetic marijuana

Page 7,065«..1020..7,0647,0657,0667,067..7,0707,080..»